Rebless 2.5mg Tablet
Marketer
Mankind Pharma Ltd
Salt Composition
Rivaroxaban (2.5mg)
Overview Rebless 2.5mg Tablet
Apox 2.5mg tablets function as an anticoagulant, preventing and treating blood clots. This medication lowers the risk of stroke and heart attack by inhibiting clot formation in leg, lung, brain, and heart veins. Frequently prescribed for individuals with atrial fibrillation to prevent clots, it also mitigates clotting risks post-knee or hip replacement. It can be administered with or without food, ideally at the same time daily for optimal efficacy. Long-term use, sometimes lifelong, may be necessary; discontinuation or dosage alteration requires physician consultation to avoid increased stroke, heart attack, or thrombosis risk. Lifestyle modifications, such as a healthy diet, regular exercise, smoking cessation, and weight management (if needed), further reduce clot risk. Increased bleeding (e.g., nosebleeds, bruising) is a common side effect; report any symptoms promptly to your doctor. Contraindicated in patients with severe liver or kidney disease, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR monitoring isn't typically needed.
Primary Ingredients of Rebless 2.5mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Rebless 2.5mg Tablet
Managing and averting blood clot formation
Major Benefits of Rebless 2.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 2.5mg Rebless Tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended for optimal results.
Common Side effects of Rebless 2.5mg Tablet:
- Bleeding
How to use Rebless 2.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 2.5mg Rebless Tablet whole; avoid crushing, chewing, or breaking it. This medication can be taken with or without food, though consistent timing is recommended.
How Rebless 2.5mg Tablet works:
Xacontrol 2.5mg tablets represent a new class of oral blood thinners. Their mechanism of action involves the inhibition of factor Xa, a key clotting protein, thus reducing the likelihood of blood clot development.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Rebless 2.5mg Tablet concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Using Rebless 2.5mg Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Rebless 2.5mg Tablets while breastfeeding is likely unsafe. Studies in humans indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving may be impaired by Rebless 2.5mg Tablet, which can induce dizziness or fainting. These side effects could compromise your ability to operate a vehicle safely.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Rebless 2.5mg tablets, potentially requiring dosage modification. Consult a physician before use. Reblass 2.5mg tablets are contraindicated in individuals with severe kidney disease.
LiverUNSAFE
The use of Rebless 2.5mg tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Seek medical advice.
What if you forget to take Rebless 2.5mg Tablet :
Should you forget a Rebless 2.5mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rebless 2.5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Morpholine and thiophene derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Xa Inhibitors for Oral Administration |





